tiprankstipranks
Advertisement
Advertisement
QuidelOrtho price target lowered to $13 from $30 at Citi
PremiumThe FlyQuidelOrtho price target lowered to $13 from $30 at Citi
11d ago
QuidelOrtho Balances Near-Term Strain With Recovery Plan
Premium
Company Announcements
QuidelOrtho Balances Near-Term Strain With Recovery Plan
11d ago
QuidelOrtho  reports adjusted Q1 EPS (4c), consensus 42c
Premium
The Fly
QuidelOrtho reports adjusted Q1 EPS (4c), consensus 42c
12d ago
QuidelOrtho completes acquisition of LEX Diagnostics
PremiumThe FlyQuidelOrtho completes acquisition of LEX Diagnostics
28d ago
Midday Fly By: PepsiCo reports mixed Q1, TSMC reports Q1 beat
Premium
The Fly
Midday Fly By: PepsiCo reports mixed Q1, TSMC reports Q1 beat
1M ago
Morning Movers: Hims & Hers jumps as FDA looks to broader peptide access
Premium
The Fly
Morning Movers: Hims & Hers jumps as FDA looks to broader peptide access
1M ago
QuidelOrtho sees Q1 free cash flow ($70M)-($65M)
PremiumThe FlyQuidelOrtho sees Q1 free cash flow ($70M)-($65M)
1M ago
QuidelOrtho price target lowered to $17 from $30 at UBS
Premium
The Fly
QuidelOrtho price target lowered to $17 from $30 at UBS
1M ago
QuidelOrtho Announces Chief Legal Officer Leadership Transition
Premium
Company Announcements
QuidelOrtho Announces Chief Legal Officer Leadership Transition
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100